Molecular mechanisms of cigarette smoke-induced proliferation of lung cells and prevention by vitamin C

Journal of Oncology

Volumn , Issue , 2011, Pages

  Dey, Neekkan ^a   Chattopadhyay, Dhruba J ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BENZOQUINONE; CASPASE 3; CIGARETTE SMOKE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; PROTEIN C FOS; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UBIQUITINATION;

EID: 80052656149     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/561862     Document Type: Article

References (58)

1. Giovino G. A., Epidemiology of tobacco use in the United States Oncogene 2002 21 48 7326 7340 (Pubitemid 35314510)
2. Sequist L. V., Chabner B. A., Lynch T. J., Longo D. L., Non-small lung cancer Harrisons Manual of Oncology 2008 New York, NY, USA McGraw Hill Medical 455 467
3. Ames B. N., Gold L. S., Willett W. C., The causes and prevention of cancer Proceedings of the National Academy of Sciences of the United States of America 1995 92 12 5258 5265
4. Choy H., Pass H. I., Rosell R., Traynor A., Chang A. E., Ganz P. A., Hayes D. F., Lung cancer Oncology 2006 New York, NY, USA Springer 545 621
5. Evan G. I., Vousden K. H., Proliferation, cell cycle and apoptosis in cancer Nature 2001 411 6835 342 348 (Pubitemid 32467043)
6. Ames B. N., Gold L. S., Chemical carcinogenesis: too many rodent carcinogens Proceedings of the National Academy of Sciences of the United States of America 1990 87 19 7772 7776 (Pubitemid 20341799)
7. Pusztai L., Cooper K., Pusztai L., Lewis C. E., Yap E., Cell proliferation and carcinogenesis Cell Proliferation in Cancer Regulatory Mechanisms of Neoplastic Cell Growth 2001 New York, NY, USA Oxford University press 1 24
8. Sekhon H. S., Wright J. L., Churg A., Cigarette smoke causes rapid cell proliferation in small airways and associated pulmonary arteries American Journal of Physiology 1994 267 5 L557 L563
9. Lemjabbar H., Li D., Gallup M., Sidhu S., Drori E., Basbaum C., Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor -converting enzyme and amphiregulin The Journal of Biological Chemistry 2003 278 28 26202 26207 (Pubitemid 36835389)
10. Luppi F., Aarbiou J., van Wetering S., Rahman I., de Boer W. I., Rabe K. F., Hiemstra P. S., Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione Respiratory Research 2005 6, article no. 140
11. Hecht S. S., Tobacco smoke carcinogens and lung cancer Journal of the National Cancer Institute 1999 91 14 1194 1210 (Pubitemid 29357186)
12. Pryor W. A., Stone K., Zang L. Y., Bermdez E., Fractionation of aqueous cigarette tar extracts: fractions that contain the tar radical cause DNA damage Chemical Research in Toxicology 1998 11 5 441 448 (Pubitemid 28242488)
13. Chatterjee I. B., Process for the isolation of a major harmful oxidant from cigarette smoke. US Patent No. 6,929,012, 2005
14. Banerjee S., Chattopadhyay R., Ghosh A., Koley H., Panda K., Roy S., Chattopadhyay D., Chatterjee I. B., Cellular and molecular mechanisms of cigarette smoke-induced lung damage and prevention by vitamin C Journal of Inflammation 2008 5, article no. 21
15. Dey N., Das A., Ghosh A., Chatterjee I. B., Activated charcoal filter effectively reduces p-benzosemiquinone from the mainstream cigarette smoke and prevents emphysema Journal of Biosciences 2010 35 2 217 230
16. Sullivan A. B., Reynolds G. F., Substituent effects on the rate of decay of p-benzosemiquinone anion radicals Journal of Physical Chemistry 1976 80 24 2671 2674
17. Abdelmohsen K., Gerber P. A., Von Montfort C., Sies H., Klotz L. O., Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43. Role of glutathione and tyrosine phosphatases The Journal of Biological Chemistry 2003 278 40 38360 38367 (Pubitemid 37221728)
18. Panda K., Chattopadhyay R., Ghosh M. K., Chattopadhyay D. J., Chatterjee I. B., Vitamin C prevents cigarette smoke induced oxidative damage of proteins and increased proteolysis Free Radical Biology and Medicine 1999 27 9-10 1064 1079 (Pubitemid 29507479)
19. Andreeff M., Goodrich D. W., Pardee A. B., Cell proliferation, differentiation, and apoptosis Holland-Frei Cancer MedicineNCBI Books 2000 5 6th 1 28
20. Panda K., Chattopadhyay R., Chattopadhyay D. J., Chatterjee I. B., Vitamin C prevents cigarette smoke-induced oxidative damage in vivo Free Radical Biology and Medicine 2000 29 2 115 124
21. Panda K., Chattopadhyay R., Chattopadhyay D., Chatterjee I. B., Cigarette smoke-induced protein oxidation and proteolysis is exclusively caused by its tar phase: prevention by vitamin C Toxicology Letters 2001 123 1 21 32 (Pubitemid 32763085)
22. Panda K., Chatterjee I. B., Preedy V. R., Failure of alpha-tocopherol to prevent cigarette smoke-induced protein oxidation. Comparison with other antioxidant vitamins Encyclopedia of vitamin E 2007 chapter 63 London, UK CABI Publishing, Oxfordshire, UK; KingsCollege 883 893
23. Bao J., Alroy I., Waterman H., Schejter E. D., Brodie C., Gruenberg J., Yarden Y., Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome The Journal of Biological Chemistry 2000 275 34 26178 26186
24. Goodman S., Nutrition and Cancer: State-of-the-Art 2003 Strasburg, Va, USA Positive Health Publications Ltd.
25. Head K. A., Ascorbic acid in the prevention and treatment of cancer Alternative Medicine Review 1998 3 3 174 186 (Pubitemid 128709127)
26. Frei B., Lawson S., Vitamin C and cancer revisited Proceedings of the National Academy of Sciences of the United States of America 2008 105 32 11037 11038
27. Stepanov I., Jensen J., Hatsukami D., Hecht S., Tobacco-specific nitrosamines in new tobacco products Nicotine and Tobacco Research 2006 8 2 309 313 (Pubitemid 43675085)
28. Wheatley-Price P., Shepherd F. A., Stewart D. J., Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer Lung Cancer: Prevention, Management and Emerging Therapies 2010 Totowa, NJ, USA Humana Press 107 138
29. Khan E. M., Lanir R., Danielson A. R., Goldkorn T., Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking FASEB Journal 2008 22 3 910 917 (Pubitemid 351348142)
30. Lynch T. J., Bell D. W., Sordella R., Gurubhagavatula S., Okimoto R. A., Brannigan B. W., Harris P. L., Haserlat S. M., Supko J. G., Haluska F. G., Louis D. N., Christiani D. C., Settleman J., Haber D. A., Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine 2004 350 21 2129 2139 (Pubitemid 38637993)
31. Fisher A. A., Labenski M. T., Malladi S., Gokhale V., Bowen M. E., Milleron R. S., Bratton S. B., Monks T. J., Lau S. S., Quinone electrophiles selectively adduct electrophile binding motifs within cytochrome c Biochemistry 2007 46 39 11090 11100 (Pubitemid 47502775)
32. Ciardiello F., De Vita F., Orditura M., Tortora G., The role of EGFR inhibitors in nonsmall cell lung cancer Current Opinion in Oncology 2004 16 2 130 135 (Pubitemid 38402525)
33. Debucquoy A., Machiels J. P., McBride W. H., Haustermans K., Integration of epidermal growth factor receptor inhibitors with preoperative chemoradiation Clinical Cancer Research 2010 16 10 2709 2714
34. Sukhramani P. S., Sukhramani P. S., Suthar M. P., EGFR kinase: potential target for cancer therapy IJPIs Journal of Pharmacology and Toxicology 2010 1 1
35. Oda K., Matsuoka Y., Funahashi A., Kitano H., A comprehensive pathway map of epidermal growth factor receptor signaling Molecular Systems Biology 2005 1
36. Srensen O. E., Thapa D. R., Roupé K. M., Valore E. V., Sjbring U., Roberts A. A., Schmidtchen A., Ganz T., Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor Journal of Clinical Investigation 2006 116 7 1878 1885 (Pubitemid 44033312)
37. Huang F., Kirkpatrick D., Jiang X., Gygi S., Sorkin A., Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain Molecular Cell 2006 21 6 737 748 (Pubitemid 43376125)
38. Jiang X., Sorkin A., Epidermal growth factor receptor internalization through clathrin-coated pits requires Cbl RING finger and proline-rich domains but not receptor polyubiquitylation Traffic 2003 4 8 529 543 (Pubitemid 36896545)
39. Mosesson Y., Shtiegman K., Katz M., Zwang Y., Vereb G., Szollosi J., Yarden Y., Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation The Journal of Biological Chemistry 2003 278 24 21323 21326 (Pubitemid 36792525)
40. Levkowitz G., Waterman H., Ettenberg S. A., Katz M., Tsygankov A. Y., Alroy I., Lavi S., Iwai K., Reiss Y., Ciechanover A., Lipkowitz S., Yarden Y., Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1 Molecular Cell 1999 4 6 1029 1040 (Pubitemid 30054908)
41. Vivanco I., Sawyers C. L., The phosphatidylinositol 3-kinase-AKT pathway in human cancer Nature Reviews Cancer 2002 2 7 489 501 (Pubitemid 37328931)
42. Luo J., Manning B. D., Cantley L. C., Targeting the PI3K-Akt pathway in human cancer: rationale and promise Cancer Cell 2003 4 4 257 262 (Pubitemid 37329790)
43. Vicent S., Lpez-Picazo J. M., Toledo G., Lozano M. D., Torre W., Garcia-Corchn C., Quero C., Soria J. C., Martn-Algarra S., Manzano R. G., Montuenga L. M., ERK 1/2 is activated in non-small-cell lung cancer and associated with advanced tumours British Journal of Cancer 2004 90 5 1047 1052 (Pubitemid 38495827)
44. Vicent S., Lpez-Picazo J. M., Toledo G., Lozano M. D., Torre W., Garcia-Corchn C., Quero C., Soria J. C., Martn-Algarra S., Manzano R. G., Montuenga L. M., ERK 1/2 is activated in non-small-cell lung cancer and associated with advanced tumours British Journal of Cancer 2004 90 5 1047 1052 (Pubitemid 38495827)
45. Henson E. S., Gibson S. B., Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy Cellular Signalling 2006 18 12 2089 2097 (Pubitemid 44642342)
46. Huang R. P., Peng A., Golard A., Hossain M. Z., Huang R., Liu Y. G., Boynton A. L., Hydrogen peroxide promotes transformation of rat liver non-neoplastic epithelial cells through activation of epidermal growth factor receptor Molecular Carcinogenesis 2001 30 4 209 217 (Pubitemid 32402176)
47. Patel J. H., McMahon S. B., BCL2 is a downstream effector of MIZ-1 essential for blocking c-MYC-induced apoptosis The Journal of Biological Chemistry 2007 282 1 5 13 (Pubitemid 47076659)
48. Nesbit C. E., Tersak J. M., Prochownik E. V., MYC oncogenes and human neoplastic disease Oncogene 1999 18 19 3004 3016 (Pubitemid 29276540)
49. Pelengaris S., Khan M., Evan G., c-MYC: more than just a matter of life and death Nature Reviews Cancer 2002 2 10 764 776 (Pubitemid 37328911)
50. Noguchi K., Kitanaka C., Yamana H., Kokubu A., Mochizuki T., Kuchino Y., Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c- Jun N-terminal kinase The Journal of Biological Chemistry 1999 274 46 32580 32587 (Pubitemid 129535283)
51. Dobrzanski P., Noguchi T., Kovary K., Rizzo C. A., Lazo P. S., Bravo R., Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts Molecular and Cellular Biology 1991 11 11 5470 5478 (Pubitemid 21895312)
52. Rosenberger S. F., Finch J. S., Gupta A., Bowden G. T., Extracellular signal-regulated kinase 1/2-mediated phosphorylation of jund and fosb is required for okadaic acid-induced activator protein 1 activation The Journal of Biological Chemistry 1999 274 2 1124 1130 (Pubitemid 29058089)
53. Sasaki T., Kojima H., Kishimoto R., Ikeda A., Kunimoto H., Nakajima K., Spatiotemporal regulation of c-Fos by ERK5 and the E3 ubiquitin ligase UBR1, and its biological role Molecular Cell 2006 24 1 63 75 (Pubitemid 44466681)
54. Basbous J., Chalbos D., Hipskind R., Jariel-Encontre I., Piechaczyk M., Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer Molecular and Cellular Biology 2007 27 11 3936 3950 (Pubitemid 47010992)
55. Saba N. F., Khuri F. R., Chemoprevention strategies for patients with lung cancer in the context of screening Clinical Lung Cancer 2005 7 2 92 99 (Pubitemid 43192124)
56. Peled N., Keth R. L., Hirsch F. R., Stewart D. J., Lung cancer prevention Lung Cancer: Prevention, Management and Emerging Therapies 2010 Totowa, NJ, USA Humana Press 107 138
57. da Cunha Santos G., Shepherd F. A., Tsao M. S., EGFR Mutations and Lung Cancer Annual Review of Pathology 2011 6 49 69
58. Ready N., Inhibition of the epidermal growth factor receptor in combined modality treatment for locally advanced non-small cell lung cancer Seminars in Oncology 2005 32 3 S35 S41